{"schema_version":"secwatch.filing_event.v1","accession":"0001650664-25-000031","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.311230+00:00","generated_at":"2026-05-24T10:16:41.134518+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Editas Medicine CFO resigns; Amy Parison appointed as CFO","bullets":["Erick Lucera resigns as EVP, CFO effective March 28, 2025.","Amy Parison, previously SVP Finance, appointed SVP, CFO and Treasurer effective March 28, 2025.","Parison receives $415k base salary, 40% target bonus, and option for 34,672 shares vesting monthly over 4 years.","Parison joined Editas in Aug 2022 as VP Finance, Corporate Controller, promoted to SVP Finance Jan 2025.","No arrangement or understanding behind Parison's selection; no reportable transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001650664-25-000031","json":"https://secwatch.observer/filing/0001650664-25-000031.json","markdown":"https://secwatch.observer/filing/0001650664-25-000031.md","text":"https://secwatch.observer/filing/0001650664-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/edit-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T10:16:41.134518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e3badb0e0","claim":"Erick Lucera departed as Executive Vice President, Chief Financial Officer at Editas Medicine, Inc..","evidence_excerpt":"On March 18, 2025, Erick Lucera, Executive Vice President, Chief Financial Officer of Editas Medicine, Inc. (the “Company”) informed the Company that he will be resigning from his position effective March 28, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Executive Vice President, Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"970c987867","claim":"Amy Parison was appointed as Senior Vice President, Chief Financial Officer and Treasurer at Editas Medicine, Inc..","evidence_excerpt":"In connection with Mr. Lucera’s resignation, on March 19, 2025 the Company appointed Amy Parison, Senior Vice President, Finance as Senior Vice President, Chief Financial Officer and Treasurer of the Company, to be effective as of the close of business on March 28, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}